Paltusotine not checked

Crinetics Pharmaceuticals Inc. · CRN00808

FollowEvery change as it happens, and a Monday email
Stage
in the US · approved in the EU
Next date
Phase 3 trial completes
Trials
1 active
6 in total · 4 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum, Carcinoid Tumor of Cecum, Carcinoid Tumor of Liver, Carcinoid Tumor of Pancreas, Carcinoid Syndrome Diarrhea and 1 more
Main trialPhase 3
“A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. The purpose of this study is to continue the evaluation of the safety, efficacy, and pharmacokinetics (PK) of paltusotine in participants with carcinoid syndrome.”In the company’s words, NCT07087054 on ClinicalTrials.gov
Other names
CRN00808

Other drugs for Carcinoid

All 4 drugs for Carcinoid

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Aug 2027 Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Phase 3Terminated 10 Jul 2023 A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
Phase 3Terminated 20 Jan 2024 A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
Phase 2Completed 15 Jul 2020 A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
Phase 2Completed 3 Aug 2020 An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)
Phase 2Terminated 30 Jun 2026 A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Paltusotine

Following is part of Solo: you see every change to Paltusotine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in